MicroRNA‑335 inhibits bladder cancer cell growth and migration by targeting mitogen‑activated protein kinase 1

Xiaolin Wang1, Guang Wu2, Guangxin Cao1

  • 1Department of Urology, Nantong Tumor Hospital, Nantong, Jiangsu 226361, P.R. China.

Insights

MicroRNA-335 (miR-335) is downregulated in bladder cancer, acting as a tumor suppressor. Its reduced expression correlates with aggressive cancer, while restoring miR-335 inhibits proliferation and metastasis by targeting MAPK1.

Area of Science:

  • Molecular Oncology
  • Cancer Biology

Background:

  • MicroRNAs (miRs) play critical roles as oncogenes or tumor suppressors in various cancers.
  • The specific function of miR-335 in bladder cancer remains largely uncharacterized.

Purpose of the Study:

  • To investigate the expression levels of miR-335 in bladder cancer tissues.
  • To determine the impact of miR-335 on bladder cancer cell proliferation, apoptosis, and metastasis.
  • To identify potential molecular targets of miR-335 in bladder cancer.

Main Methods:

  • Quantitative PCR and Western blot analysis to assess miR-335 and MAPK1 expression.
  • MTT assay for cell proliferation assessment.
  • Flow cytometry for apoptosis analysis.
  • Transwell assay for cell migration evaluation.
  • Gene silencing techniques to validate target interactions.

Main Results:

  • miR-335 was significantly downregulated in bladder cancer tissues, with lower levels associated with aggressive disease phenotypes.
  • Overexpression of miR-335 inhibited T24 bladder cancer cell proliferation and induced apoptosis.
  • Restoring miR-335 levels suppressed cell migration and invasion.
  • Mitogen-activated protein kinase (MAPK)1 expression was reduced upon miR-335 overexpression, suggesting MAPK1 as a direct target.
  • Silencing MAPK1 mimicked the inhibitory effects of miR-335 on proliferation and migration.

Conclusions:

  • miR-335 functions as a tumor suppressor in bladder cancer.
  • The tumor-suppressive role of miR-335 is mediated, at least in part, through the repression of MAPK1.
  • miR-335 represents a potential therapeutic target for bladder cancer treatment.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.5K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K